Free Trial

Value Stocks To Add to Your Watchlist - April 7th

Invesco QQQ logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • MarketBeat's screener names five Value stocks to watch: Invesco QQQ (QQQ), SanDisk (SNDK), Intel (INTC), ProShares UltraPro Short QQQ (SQQQ), and Terns Pharmaceuticals (TERN).
  • Value stocks are shares that appear priced below their intrinsic worth based on fundamentals (like earnings, cash flow, or book value) and often attract investors for low P/E or P/B ratios and potential dividends, though they can remain undervalued for extended periods.
  • These companies were selected because they had the highest dollar trading volume among Value stocks in recent days, signaling notable market activity and liquidity.
  • Five stocks to consider instead of Invesco QQQ.

Invesco QQQ, Sandisk, Intel, ProShares UltraPro Short QQQ, and Terns Pharmaceuticals are the five Value stocks to watch today, according to MarketBeat's stock screener tool. Value stocks are shares of companies that appear priced below their intrinsic worth based on fundamentals like earnings, cash flow, or book value. Investors buy them expecting the market will eventually recognize that undervaluation—often attracted by low price-to-earnings or price-to-book ratios and potential dividends—though such stocks can stay cheap for extended periods. These companies had the highest dollar trading volume of any Value stocks within the last several days.

Invesco QQQ (QQQ)

PowerShares QQQ Trust, Series 1 is a unit investment trust that issues securities called Nasdaq-100 Index Tracking Stock. The Trust's investment objective is to provide investment results that generally correspond to the price and yield performance of the Nasdaq-100 Index. The Trust provides investors with the opportunity to purchase units of beneficial interest in the Trust representing proportionate undivided interests in the portfolio of securities held by the Trust, which consists of substantially all of the securities, in substantially the same weighting, as the component securities of the Nasdaq-100 Index.

Read Our Latest Research Report on QQQ

Sandisk (SNDK)

SanDisk Corporation offers flash storage solutions. The Company designs, develops and manufactures data storage solutions in a range of form factors using flash memory, controller, firmware and software technologies. The Company operates through flash memory storage products segment. Its solutions include a range of solid state drives (SSD), embedded products, removable cards, universal serial bus (USB), drives, wireless media drives, digital media players, and wafers and components.

Read Our Latest Research Report on SNDK

Intel (INTC)

Intel Corporation designs, develops, manufactures, markets, and sells computing and related products and services worldwide. It operates through Client Computing Group, Data Center and AI, Network and Edge, Mobileye, and Intel Foundry Services segments. The company's products portfolio comprises central processing units and chipsets, system-on-chips (SoCs), and multichip packages; mobile and desktop processors; hardware products comprising graphics processing units (GPUs), domain-specific accelerators, and field programmable gate arrays (FPGAs); and memory and storage, connectivity and networking, and other semiconductor products.

Read Our Latest Research Report on INTC

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

Read Our Latest Research Report on SQQQ

Terns Pharmaceuticals (TERN)

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow.

Read Our Latest Research Report on TERN

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Invesco QQQ Right Now?

Before you consider Invesco QQQ, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Invesco QQQ wasn't on the list.

While Invesco QQQ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines